Gary F Gerlach has completed her Ph.D. from the University of Zurich, International Graduate School in Life Science, and Postdoctoral studies from Oxford University Radcliffe Department of Medicine. She was Visiting Scientist at the Department of Bioengineering and Applied Science (DEAS), Harvard University, Cambridge, MA, USA where she helped to develop a new method of molecular drug delivery from electro-polymerized micro- and nano-patterned surfaces. She has published 6 papers in reputed journals and has been serving Zurich Cancer Network, European Association for Cancer Research (EACR), University of Oxford Club and NHS Trust as a Member.       Gary F Gerlach has completed her Ph.D. from the University of Zurich, International Graduate School in Life Science, and Postdoctoral studies from Oxford University Radcliffe Department of Medicine. She was Visiting Scientist at the Department of Bioengineering and Applied Science (DEAS), Harvard University, Cambridge, MA, USA where she helped to develop a new method of molecular drug delivery from electro-polymerized micro- and nano-patterned surfaces. She has published 6 papers in reputed journals and has been serving Zurich Cancer Network, European Association for Cancer Research (EACR), University of Oxford Club and NHS Trust as a Member.

Genetics and Molecular Biology